Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Palliative Medicine|March 19, 2020
Repeated subcutaneous esketamine administration for depressive symptoms and pain relief in a terminally ill cancer patient: A case reportMatheus Ghossain Barbosa, Rodrigo Simonini Delfino, Luciana Maria Sarin, et al.Journal of Affective Disorders|October 5, 2020
Comparative effectiveness of esketamine in the treatment of anhedonia in bipolar and unipolar depressionRodrigo Simonini Delfino, José Alberto Del-Porto, Juliana Surjan, et al.Journal of Affective Disorders|April 4, 2026
Role of concomitant benzodiazepines, lithium, and lamotrigine in modulating the antidepressant effects of subcutaneous esketamine in patients with treatment-resistant depressive episodes: A retrospective naturalistic studyJoão Paulo Atidio, Rodrigo Simonini Delfino, Igor Saque Garios, et al.Revista De Psiquiatria Y Salud Mental|December 4, 2021
The probability of response after each subcutaneous injection of esketamine in treatment-resistant depressionVictor Augusto Rodovalho Fava, Luciana Maria Sarin, Ana Cecília Lucchese, et al.Revista De Psiquiatria Y Salud Mental|October 19, 2020
The probability of response after each subcutaneous injection of esketamine in treatment-resistant depressionVictor Augusto Rodovalho Fava, Luciana Maria Sarin, Ana Cecília Lucchese, et al.Clinical Drug Investigation|August 31, 2022
Efficacy and Safety of Subcutaneous Esketamine in the Treatment of Suicidality in Major Depressive Disorder and Bipolar DepressionJuliana Surjan, Julia Diniz Grossi, José Alberto Del Porto, et al.Frontiers in Psychiatry|September 6, 2021
A Clinical Rationale for Assessing the Impact of Childhood Sexual Abuse on Adjunctive Subcutaneous Esketamine for Treatment-Resistant DepressionEduardo Jorge Muniz Magalhães, Luciana Maria Sarin, Lorena Catarina Del Sant, et al.Pageof 1